Integra LifeSciences Schedules Conference Call for Monday, March 14 to

    Business Editors

    PLAINSBORO, N.J.--(BUSINESS WIRE)--Feb. 25, 2005--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Monday, March 14 to discuss financial results for the fourth quarter and year ended December 31, 2004 and to update forward-looking financial guidance. Financial results for the fourth quarter and full year 2004 will be announced via a news release issued on March 13.

    The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward- looking information may be discussed in a question and answer session following the call.

    Access to the live call is available by dialing 973-935-8511 or through a webcast via a link provided on Integra's website at www.Integra-LS.com. Access to a replay is available through March 28, 2005 by dialing 973-341-3080 (PIN 5630772) or through the webcast.

    Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neuro-trauma and neurosurgery, reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.

--30--VS/cg*

CONTACT: Integra LifeSciences Holdings Corporation Maria Platsis, 609-936-2333 mplatsis@integra-ls.com or John Bostjancic, 609-936-2239 jbostjancic@integra-ls.com

KEYWORD: NEW JERSEY INDUSTRY KEYWORD: MEDICAL DEVICES BIOTECHNOLOGY CONFERENCE CALLS SOURCE: Integra LifeSciences Holdings Corporation

Copyright Business Wire 2005